Indraprastha Medical Corporation Limited Approves FY2026 Results, Recommends 40% Dividend
Indraprastha Medical Corporation Limited (Apollo Hospitals) announced that its Board of Directors held a meeting on May 12, 2026. During the meeting, the Board approved the Audited Financial Statements and Financial Results for the year ended March 31, 2026. Furthermore, the company recommended a dividend of 40%, totaling Rs. 4.00 per equity share, for the financial year 2025-26, pending shareholder approval at the Annual General Meeting (AGM).The company confirmed that the statutory auditors have issued an Unmodified Opinion on the Annual Audited Financial Results for the financial year ended March 31, 2026.
Financial Performance Highlights (FY2026)
The Board's approved results provide a detailed view of the company's performance. The full financial results for the quarter/year ended March 31, 2026, showed a Total income of 1511.26 (Rs. in crore). Total expenses for the same period were 1265.24 (Rs. in crore), resulting in a Profit before tax (PBT) of 246.02 (Rs. in crore).The company’s financial standing was detailed across several key reports.
Statement of Audited Financial Results (Rs. in crore)
| Particulars | Quarter ended 31.03.2026 (Audited) | Year ended 31.03.26 (Audited) |
|---|---|---|
| Revenue from operations | 364.81 | 1482.51 |
| Total income | 372.14 | 1511.26 |
| Total expenses | 317.13 | 1265.24 |
| Profit before tax (PBT) | 55.01 | 246.02 |
| Profit for the period after tax (PAT) | 41.70 | 183.62 |
| Total comprehensive income for the period | 40.56 | 184.94 |
Statement of Assets and Liabilities (Rs. in crore)
| Particulars | As at 31.03.2026 (Audited) | As at 31.03.2025 (Audited) |
|---|---|---|
| TOTAL OF ASSETS | 991.36 | 851.62 |
| Non-current assets (Total) | 574.77 | 420.49 |
| Current assets (Total) | 416.59 | 431.13 |
| TOTAL OF EQUITY AND LIABILITIES | 991.36 | 851.62 |
| Equity share capital | 91.67 | 91.67 |
| Other equity | 648.70 | 505.01 |
| TOTAL LIABILITIES | 169.55 | 178.71 |
Cash Flow Summary
The cash flow analysis demonstrated the company’s liquidity status over the last fiscal year.Statement of Cash Flows (Rs. in crore)
| Particulars | Year ended 31.03.2026 (Audited) | Year ended 31.03.2025 (Audited) |
|---|---|---|
| Net cash generated from operating activities | 167.44 | 156.75 |
| Net cash used in investing activities | (177.61) | (110.99) |
| Net cash used in financing activities | (46.38) | (45.88) |
| Net increase / (decrease) in cash and cash equivalents | (56.55) | (0.12) |
Future Outlook
The company stated that it will inform stakeholders in due course regarding the date of the Annual General Meeting (AGM) for the year ended March 31, 2026, and the subsequent date when the dividend, if approved by shareholders, will be paid.INDRAMEDCO Stock Price Movement
Shares of Indraprastha Medical Corporation Limited today slipped by 4.09% to settle at ₹415.85. The stock recorded a trading range between ₹413.6 and ₹441, with a total volume of 342,953 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.